4 studies found for: "RWJMS" OR "Robert Wood Johnson Medical School" OR "Cancer Institute of New Jersey" OR "CINJ" | Open Studies | "Hodgkin Disease"
Ipilimumab, Nivolumab, and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Brentuximab Vedotin and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed Hodgkin Lymphoma
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies
† Study has passed its completion date and status has not been verified in more than two years.